RWE AG INH O.N./ DE0007037129 /
| 2024-07-31 9:59:01 PM | Chg. +0.180 | Volume | Bid10:00:02 PM | Ask10:00:02 PM | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 34.370EUR | +0.53% | 8,241 Turnover: 284,337.790 |
-Bid Size: - | -Ask Size: - | 25.64 bill.EUR | 2.90% | 17.68 |
GlobeNewswire
06-25
Annexon Presented Additional Positive Phase 3 Results for ANX005 C1q-Targeted Immunotherapy in Guill...
GlobeNewswire
06-18
Truveta announces support for regulatory submissions to the FDA and global regulatory authorities
GlobeNewswire
06-12
RWE Announces Start of Site Investigation Campaign for its Canopy Offshore Wind Project off the Coas...
GlobeNewswire
06-11
RWE begins onsite construction on its first utility-scale solar project in Illinois to support rapid...
GlobeNewswire
06-05
Intuitive Announces FDA Clearance of Revised da Vinci Xi and X Labeling on Radical Prostatectomy
GlobeNewswire
06-04
Annexon Announces Positive Topline Results from Pivotal Phase 3 Trial for First-in-Class C1q Blockin...
GlobeNewswire
05-23
RWE signs two 15-year Power Purchase Agreements with Microsoft to supply clean energy from two onsho...
GlobeNewswire
05-20
RWE expands U.S. development portfolio with new project acquisitions across three states
GlobeNewswire
05-13
Annexon Reports First Quarter 2024 Financial Results and Key Anticipated Milestones
GlobeNewswire
05-02
Using clinical-led AI, Truveta expands clinical notes and medical images available to advance resear...
GlobeNewswire
04-25
Truveta delivers largest and most complete mother and child EHR dataset to advance healthcare
